(Q37697321)

22 August 2017

1 reference

title

Proposed changes to management of lower respiratory tract infections in response to the Clostridium difficile epidemic (English)

1 reference

22 August 2017

main subject

Clostridium difficile

0 references

1

James D Chalmers

1 reference

22 August 2017

Mudher Al-Khairalla

2

1 reference

22 August 2017

Philip M Short

series ordinal

3

1 reference

22 August 2017

Tom C Fardon

series ordinal

4

1 reference

22 August 2017

John H Winter

series ordinal

5

1 reference

22 August 2017

language of work or name

English

0 references

publication date

23 February 2010

1 reference

Journal of Antimicrobial Chemotherapy

22 August 2017

published in

1 reference

22 August 2017

volume

65

1 reference

22 August 2017

issue

4

1 reference

22 August 2017

page(s)

608-618

1 reference

BTS guidelines for the management of community acquired pneumonia in adults: update 2009

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Practices to improve antimicrobial use at 47 US hospitals: the status of the 1997 SHEA/IDSA position paper recommendations. Society for Healthcare Epidemiology of America/Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Increasing hospital admissions for pneumonia, England

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Impact of changes in antibiotic policy on Clostridium difficile-associated diarrhoea (CDAD) over a five-year period in a district general hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Isolation measures in the hospital management of methicillin resistant Staphylococcus aureus (MRSA): systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Antibiotic prescribing--are there lessons for physicians?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Clostridium difficile ribotypes 027 and 106: clinical outcomes and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Increased risk of diarrhoea caused by Clostridium difficile in elderly patients receiving cefotaxime.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Hospital-acquired Clostridium difficile diarrhoea and herd immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Successful control of Clostridium difficile infection in an elderly care unit through use of a restrictive antibiotic policy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Respiratory antibiotic use and clostridium difficile infection: is it the drugs or is it the doctors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Antimicrobial drug use and methicillin-resistant Staphylococcus aureus, Aberdeen, 1996-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Local antibiotic guidelines for adult community-acquired pneumonia (CAP): a survey of UK hospital practice in 1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Systematic review of antimicrobial drug prescribing in hospitals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Clostridium difficile infection associated with antineoplastic chemotherapy: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Systematic review of the risk of enteric infection in patients taking acid suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Clostridium difficile and inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Room for improvement: a systematic review of the quality of evaluations of interventions to improve hospital antibiotic prescribing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Antimicrobial susceptibility of community-acquired respiratory tract pathogens in the UK during 2002/3 determined locally and centrally by BSAC methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Respiratory fluoroquinolones for the treatment of community-acquired pneumonia: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Effect of fluoroquinolone treatment on growth of and toxin production by epidemic and nonepidemic clostridium difficile strains in the cecal contents of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Empiric antibiotic therapy and mortality among medicare pneumonia inpatients in 10 western states : 1993, 1995, and 1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Antimicrobial selection for hospitalized patients with presumed community-acquired pneumonia: a survey of nonteaching US community hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Comparison of beta-lactam and macrolide combination therapy versus fluoroquinolone monotherapy in hospitalized Veterans Affairs patients with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Combination Antibiotic Therapy Lowers Mortality among Severely Ill Patients with Pneumococcal Bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Lower mortality among patients with community-acquired pneumonia treated with a macrolide plus a beta-lactam agent versus a beta-lactam agent alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Impact of intravenous {beta}-lactam/macrolide versus {beta}-lactam monotherapy on mortality in hospitalized patients with community-acquired pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Clarithromycin appears to be linked with Clostridium difficile-associated diarrhoea in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Health care resource utilization and antimicrobial use in elderly patients with community-acquired lower respiratory tract infection who develop Clostridium difficile-associated diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Antibiotics for community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Successful use of feedback to improve antibiotic prescribing and reduce Clostridium difficile infection: a controlled interrupted time series

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Swedish guidelines for the management of community-acquired pneumonia in immunocompetent adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Management of patients with community-acquired pneumonia treated in hospital in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Non-susceptibility trends and serotype distributions among Streptococcus pneumoniae from community-acquired respiratory tract infections and from bacteraemias in the UK and Ireland, 1999 to 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Community-acquired pneumonia: doctors do not follow national guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

A prediction rule to identify low-risk patients with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Prospective comparison of three predictive rules for assessing severity of community-acquired pneumonia in Hong Kong

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

A prospective comparison of severity scores for identifying patients with severe community acquired pneumonia: reconsidering what is meant by severe pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Prognostic score systems and community-acquired bacteraemic pneumococcal pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Validation of a predictive rule for the management of community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

The CURB65 pneumonia severity score outperforms generic sepsis and early warning scores in predicting mortality in community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Sulindac-induced aseptic meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Severity assessment in community-acquired pneumonia: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Diagnostic value of C reactive protein in infections of the lower respiratory tract: systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Procalcitonin Guidance of Antibiotic Therapy in Community-acquired Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Risk factors for acquisition of Clostridium difficile-associated diarrhea among outpatients at a cancer hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Efficacy of short-course antibiotic regimens for community-acquired pneumonia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Effectiveness of early switch from intravenous to oral antibiotics in severe community acquired pneumonia: multicentre randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Instability on hospital discharge and the risk of adverse outcomes in patients with pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Early switch from intravenous to oral antibiotics in hospitalized patients with bacteremic community-acquired Streptococcus pneumoniae pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Misdiagnosis of community-acquired pneumonia and inappropriate utilization of antibiotics: side effects of the 4-h antibiotic administration rule

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Reducing door-to-antibiotic time in community-acquired pneumonia: Controlled before-and-after evaluation and cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Antibiotic use in patients admitted with acute exacerbations of chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Declining length of hospital stay for pneumonia and postdischarge outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Effect of Macrolides as Part of Initial Empiric Therapy on Length of Stay in Patients Hospitalized With Community-Acquired Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ038

21 January 2018

Identifiers

DOI

10.1093/JAC/DKQ038

1 reference

22 August 2017

1 reference